Breath Biopsy Breath Biopsy platform scoops the UK’s most prestigious award for engineering innovation
Breath Biopsy Owlstone Medical provides Breath Biopsy Services to AstraZeneca to study disease drivers in Asthma and COPD
Company Updates Owlstone Medical raises $15 million USD (£11 million GBP) with Horizons Ventures and Aviva
Breath Biopsy Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial